Virtu Financial’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,172
Closed -$13K 2261
2024
Q3
$13K Buy
+23,172
New +$13K ﹤0.01% 1179
2023
Q1
Sell
-29,423
Closed -$102K 2247
2022
Q4
$102K Sell
29,423
-22,438
-43% -$64.1K 0.01% 958
2022
Q3
$133K Buy
51,861
+34,864
+205% +$111K 0.01% 1006
2022
Q2
$41K Buy
+16,997
New +$44.6K ﹤0.01% 1176
2021
Q3
Sell
-30,386
Closed -$277K 2077
2021
Q2
$277K Sell
30,386
-32,291
-52% -$299K 0.03% 774
2021
Q1
$591K Buy
+62,677
New +$863K 0.04% 443
2020
Q4
Sell
-11,342
Closed -$30K 1877
2020
Q3
$30K Sell
11,342
-5,054
-31% -$18.8K 0.01% 889
2020
Q2
$109K Buy
+16,396
New +$110K 0.01% 866

Other funds holding GRTS

Virtu Financial's GRTS Position: Q4 2024 in Review

Virtu Financial sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 23,172 shares — an estimated $13K sold.

Virtu Financial first reported a position in GRTS in Q2 2020 and held it in 8 quarters. The position peaked at $591K in Q1 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Virtu Financial reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 23,172 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $13K.
  • Virtu Financial first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Virtu Financial's Gritstone bio, Inc. Common Stock position peaked at $591K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.